The incidence risk of elevated fasting blood glucose in people with fatty liver disease: a cohort study of 40 000 people over the past 10 years
10.3760/cma.j.cn501113-20190806-00293
- VernacularTitle:脂肪肝患者发生空腹血糖升高的风险：一项40 381人近10年的队列研究
- Author:
Jiang DENG
1
;
Kuanqian TUO
;
Jianning LI
;
Xiaoling LI
;
Jingyuan XU
;
Xiaolan LU
Author Information
1. 西安交通大学第二附属医院消化科 710004
- Keywords:
Fatty liver;
Fasting blood glucose;
Survival analysis;
Risk factors
- From:
Chinese Journal of Hepatology
2021;29(5):446-450
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the time point when patients with fatty liver disease had a significantly higher risk of elevated fasting blood glucose than those without in the physical examination group in Karamay Central Hospital, factors affecting the incidence of elevated blood glucose in patients with fatty liver disease, and the influence of the number of influencing factors on it.Methods:Physical examination data from Karamay Central Hospital during September 2008 to April 2017 were retrospectively analyzed. Combined with the survival analysis, the 1-,3-, 5-, and 7-year prevalence rates of elevated fasting glucose occurs in people with and without fatty liver disease were analyzed. Z-test was used to compare the survival rate difference at each time point. Cox regression model was used for multivariate analysis.Results:10 802 people were in the fatty liver group. The elevated fasting blood glucose incidence density was 61/1 000 person-years, and the 1-, 3-, 5-, and 7-year prevalence rates were 2%, 16%, 28%, and 38%, respectively. 29 579 people were in the non-fatty liver group. The elevated fasting blood glucose incidence density was 23/1000 person-years, and the 1-, 3-, 5-, and 7-year prevalence rates were 1%, 7%, 11%, and 16%, respectively. The short-term and long-term elevated fasting blood glucose incidence risk were significantly higher in fatty liver group than non-fatty liver group( P < 0.001). The elevated fasting blood glucose incidence risk was apparently higher in fatty liver group than that of non-fatty liver group from the first year onward ( P < 0.001). Age≥50 year’s old ( HR = 1.954, 95% CI :1.792-2.132), elevated body mass index ( HR = 1.397, 95% CI : 1.198-1.629), blood pressure ( HR = 1.284, 95% CI : 1.181-1.397), triglycerides ( HR = 1.171, 95% CI: 1.077-1.274) were independent risk factors, which promoted the elevated fasting blood glucose incidence risk in patients with fatty liver disease. Fatty liver combined with the above 2, 3, and 4 risk factors had apparently increased the incidence risk of elevated fasting blood glucose ( P < 0.001). Conclusion:People with fatty liver disease had a higher risk of elevated fasting blood glucose from the first year than those without. Age≥50 year’s old, elevated blood pressure, body mass index and triglyceride might increase risk of elevated fasting blood glucose in patients with fatty liver disease, combined with the above 2,3 or 4 risk factors can increase the risk of elevated fasting blood glucose.
